Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Civista Bancshares (CIVB) Cash & Equivalents (2016 - 2025)

Civista Bancshares' Cash & Equivalents history spans 10 years, with the latest figure at $77.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 22.43% year-over-year to $77.3 million; the TTM value through Dec 2025 reached $77.3 million, up 22.43%, while the annual FY2025 figure was $77.3 million, 22.43% up from the prior year.
  • Cash & Equivalents reached $77.3 million in Q4 2025 per CIVB's latest filing, up from $7.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $434.8 million in Q1 2021 to a low of $3.0 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $114.7 million, with a median of $43.4 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: tumbled 99.26% in 2023, then skyrocketed 559.99% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $264.2 million in 2021, then tumbled by 83.59% to $43.4 million in 2022, then surged by 39.31% to $60.4 million in 2023, then increased by 4.55% to $63.2 million in 2024, then rose by 22.43% to $77.3 million in 2025.
  • Per Business Quant, the three most recent readings for CIVB's Cash & Equivalents are $77.3 million (Q4 2025), $7.0 million (Q3 2025), and $7.9 million (Q2 2025).